Investors



SEC Filings

Filing date Form Description Filing Group View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
CT ORDER

CT ORDER

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - EX-101.INS View HTML

Copyright Morningstar







© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MACRILEN is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V13 01/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
info@strongbridgebio.com

Privacy Statement
Compliance Program